3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
11
Phase 3
4
Phase EARLY_PHASE1
2
Phase NA
1
Phase 4
1
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
47
Squamous Cell Carcinoma of Head and Neck
24
Head and Neck Neoplasms
21
Lung Neoplasms
19
Neoplasms
18
Stomach Neoplasms
15
Urinary Bladder Neoplasms
14
Uterine Cervical Neoplasms
11
Small Cell Lung Carcinoma
11
Ovarian Neoplasms
11
Esophageal Neoplasms
11
Colorectal Neoplasms
11
Pancreatic Neoplasms
10
Biliary Tract Neoplasms
10
Carcinoma, Transitional Cell
9
Triple Negative Breast Neoplasms
8
Neoplasm Metastasis
8
Breast Neoplasms
8
Oropharyngeal Neoplasms
7
Mesothelioma, Malignant
7
Melanoma
7
Cholangiocarcinoma
7
Carcinoma, Squamous Cell
6
Recurrence
5
Nasopharyngeal Carcinoma
5
Mesothelioma
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma
5
Nasopharyngeal Neoplasms
4
Mouth Neoplasms
4
Interventions
Temozolomide
6
Radiotherapy
4
Irinotecan
3
lutetium Lu 177 dotatate
2
Nivolumab
2
Carboplatin
2
sonidegib
1
sodium thiosulfate
1
silmitasertib
1
poly ICLC
1
plerixafor
1
olaparib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
entrectinib
1
dinutuximab
1
bempegaldesleukin
1
adavosertib
1
abemaciclib
1
Vincristine
1
Vascular Endothelial Growth Factor A
1
Vaccines
1
Triiodothyronine
1
TPI-287
1
Surgical Procedures, Operative
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Medulloblastoma
×
Cisplatin
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled